Trials / Completed
CompletedNCT05638347
A Trial of HRS-7085 Tablet in Healthy Participants With and Without Food Effect.
Use the Protocol Title. A Phase 1, Randomized, Double-Blind, Placebo-Controlled Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Food Effect on the Pharmacokinetics of HRS-7085 in Healthy Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Atridia Pty Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The study is being conducted to evaluate the Safety, Tolerability, Pharmacokinetics, and Clinical Activity of HRS-7085.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-7085 tablets | Single oral administration |
| DRUG | Placebo tablet | Single oral administration |
Timeline
- Start date
- 2022-12-05
- Primary completion
- 2023-03-16
- Completion
- 2023-03-16
- First posted
- 2022-12-06
- Last updated
- 2023-04-21
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT05638347. Inclusion in this directory is not an endorsement.